Forte Biosciences, Inc. (FBRX)
Healthcare · Biotechnology · NASDAQ · US
$76.99+0.00%Close
BUYBULL · day 19
$76.99+0.00%
Key stats
- Market cap
- $1.6B
- Beta
- 2.65
- P/E (TTM)
- -16.77
- 1W
- +0.13%
- 1M
- +0.60%
- vs SPY 1W
- -1.43%
- vs SPY 1M
- -1.16%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Squarepoint Ops LLC Reduces Position in Forte Biosciences, Inc. $FBRX
argenx Completes Acquisition of Forte Biosciences, Inc.
Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders?
Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders?
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders
FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
Are FBRX, LXFR, HUN, OLN Obtaining Fair Deals for their Shareholders?
Halper Sadeh LLC is Investigating Whether FBRX and SAFT are Obtaining Fair Deals for their Shareholders
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders?
Forte Biosciences shares surge after argenx agrees to acquire company for $2.2B
Argenx Secures Promising Autoimmune Drug In Forte Biosciences Takeover
Dow Jones still green but Nasdaq slips to start 'massive week' as oil tumbles
